Subtherapeutic Dose of Piracetam as a Therapy Adherence Marker
Clinical trial NCT05918341 · UNKNOWN
Trial details
- NCT number
- NCT05918341
- Sponsor
- The Netherlands Cancer Institute
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-03
- Primary completion
- 2023-09-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.